# Tmunity Therapeutics

Source: https://onco.cc/companies/tmunity-therapeutics/  
OnCo record `tmunity-therapeutics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Tmunity was a Philadelphia company spun out of University of Pennsylvania research that built CAR T-cell therapies with extra features to help them fight solid tumours. Gilead's cell therapy unit Kite bought it in early 2023.

## Summary

Tmunity Therapeutics was a private, clinical-stage cell therapy company based in Philadelphia. According to Gilead's first-quarter 2023 report, Kite completed the acquisition of Tmunity in that quarter, gaining preclinical and clinical programmes including an investigational armoured CAR T technology platform intended to be applied across CAR T products to enhance anti-tumour activity, together with rapid manufacturing processes. SEC Form D filings show Tmunity was incorporated in 2015 and sold about $75 million of equity in an offering that began in October 2019 (earlier Form D filings were made in 2018). The Gilead filing attributes most of a $481 million acquired in-process R&D charge in Q1 2023 to the Tmunity acquisition, alongside payments to Arcellx and Nurix. The company website no longer resolves.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- HQ: Philadelphia, PA
- Type: cell-therapy

## Notes

- Website tmunity.com is offline; the EDGAR company page is given instead. Acquisition price not disclosed in fetched sources. The 2019 Form D does not name the series; the user's hint of a 2021 acquisition is incorrect, Gilead reports completion in Q1 2023.

## Sources

- Official website: https://www.sec.gov/edgar/browse/?CIK=0001661702
- Gilead Q1 2023 results noting completed Tmunity acquisition (8-K): https://www.sec.gov/Archives/edgar/data/882095/000088209523000014/exhibit991earningspressrel.htm
- Form D, October 2019: https://www.sec.gov/Archives/edgar/data/1661702/000166170219000001/primary_doc.xml
- SEC EDGAR filings: https://www.sec.gov/edgar/browse/?CIK=0001661702

## Connected records

- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/)
- technologies: [Armoured, logic-gated & next-gen CARs](https://onco.cc/technologies/armored-car/), [CAR-T cell therapy](https://onco.cc/technologies/car-t/)
- institutions: [Parker Institute for Cancer Immunotherapy](https://onco.cc/institutions/parker-institute/)
- companies: [Gilead Sciences (incl. Kite)](https://onco.cc/companies/gilead/)

---
JSON: https://onco.cc/api/v1/entities/tmunity-therapeutics.json